Why the study?
Mortality risk from COPD increases significantly in the first year after a 30-day hospital readmission.
Does a comprehensive and collaborative pharmacist transitions of care service reduce a 180-day composite of COPD-related hospitalizations and ED visits in underserved adult patients hospitalized with COPD exacerbation?
Population
Underserved adult patients hospitalized with a primary diagnosis of COPD exacerbation
Comparison
Pharmacist transitions of care service vs usual care
Design
Within-site retrospective study
Follow-up
180 days
Key result
A comprehensive pharmacist transitions of care service significantly reduced the 180-day composite of COPD-related hospitalizations and ED visits compared to usual care (mean difference 0.82).
Authors
Loading...
Should not yet change practice; leaves open confirmation of benefit in randomized trials.
Observational (n=65)
No
Does a comprehensive and collaborative pharmacist transitions of care service reduce a 180-day composite of COPD-related hospitalizations and ED visits in underserved adult patients hospitalized with COPD exacerbation?
Effect estimate: Mean difference 0.82 (95% CI 0.05-1.60)
Absolute Event Rate: 35% vs 80%
p-value: p=0.0364
A comprehensive pharmacist transitions of care service significantly reduces 30-day COPD-related hospital readmissions and ED visits in underserved patients.
Kim et al. (2020) conducted an observational in Chronic Obstructive Pulmonary Disease (COPD) exacerbation (n=65). Comprehensive and collaborative pharmacist transitions of care service vs. Usual care was evaluated on 180-day composite of COPD-related hospitalizations and emergency department (ED) visits (Mean difference 0.82, 95% CI 0.05-1.60, p=0.0364). A comprehensive pharmacist transitions of care service significantly reduced the 180-day composite of COPD-related hospitalizations and ED visits compared to usual care (mean difference 0.82).